However, only two of them are use nucleic acid-based vaccines testing liposomal form of mRNA encoding three tumor-associated antigens (TAAs) specific for ovarian cancer and plasmid-based DNA vaccine encoding the ICD of HER2 (NCT Numbers: NCT00436254 and NCT04163094, respectively). The gene discussed is ERBB2; the disease is neoplasm.